Skip Navigation


NDT Advance Access originally published online on March 29, 2007
Nephrology Dialysis Transplantation 2007 22(7):1974-1978; doi:10.1093/ndt/gfl849
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/7/1974    most recent
gfl849v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nguyen, P. T. H.
Right arrow Articles by Jadoul, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, P. T. H.
Right arrow Articles by Jadoul, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Identification of current smokers among renal transplant recipients

Pauline T. H. Nguyen1, Laurence Galanti2, Yves Pirson1 and Michel Jadoul1

1Nephrology, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels and 2Clinical Biology, Cliniques Universitaires de Mont-Godinne, Université catholique de Louvain, Yvoir, Belgium

Correspondence and offprint requests to: Prof. Michel Jadoul, Department of Nephrology, Cliniques universitaires St Luc, Université catholique de Louvain, 10 Avenue Hippocrate, B-1200 Brussels, Belgium. Email: jadoul{at}nefr.ucl.ac.be



  Abstract

Background. In renal transplant recipients, smoking is associated with a high burden of cardiovascular disease and a higher risk of graft loss. Surprisingly, the results of measurement of cotinine serum level, the gold standard for the detection of active smoking, have not been confronted with self-reported smoking history in this group.

The aim of our study was to identify and characterize the smoking group of renal transplant recipients.

Methods. Cotinine serum level was measured and all patients were asked to fill out an anonymized questionnaire on smoking history.

Results. Out of 233 renal transplant recipients, 106 (45%) reported to be lifetime and current non-smokers: cotinine serum level was below detection limit in all; among the 127 renal transplant recipients (55%) with a lifetime history of smoking, cotinine level was diagnostic of current smoking in 32 (25%). Only 21 of the current smokers (66%) declared to the nephrologist that they had continued smoking whereas 11 (34%) claimed to be non-smokers. Current smokers were younger (P = 0.01) than former smokers.

Conclusion. The identification of current smokers among renal transplant recipients should start with questioning about lifetime history of smoking and if positive, measurement of cotinine serum level. Indeed up to 34% of current smokers do not acknowledge they are active smokers and would otherwise not offer to participate in programmes to stop smoking.

Keywords: current smoking; past smoking; renal transplantation; serum cotinine

Received for publication: 24. 7.06
Accepted in revised form: 2. 1.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.